\documentclass[twocolumn,twoside]{article}
\makeatletter\if@twocolumn\PassOptionsToPackage{switch}{lineno}\else\fi\makeatother

\usepackage{amsfonts,amssymb,amsbsy,latexsym,amsmath,tabulary,graphicx,times,xcolor}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Following additional macros are required to function some 
% functions which are not available in the class used.
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\usepackage{url,multirow,morefloats,floatflt,cancel,tfrupee}
\makeatletter


\AtBeginDocument{\@ifpackageloaded{textcomp}{}{\usepackage{textcomp}}}
\makeatother
\usepackage{colortbl}
\usepackage{xcolor}
\usepackage{pifont}
\usepackage[nointegrals]{wasysym}
\urlstyle{rm}
\makeatletter

%%%For Table column width calculation.
\def\mcWidth#1{\csname TY@F#1\endcsname+\tabcolsep}

%%Hacking center and right align for table
\def\cAlignHack{\rightskip\@flushglue\leftskip\@flushglue\parindent\z@\parfillskip\z@skip}
\def\rAlignHack{\rightskip\z@skip\leftskip\@flushglue \parindent\z@\parfillskip\z@skip}

%Etal definition in references
\@ifundefined{etal}{\def\etal{\textit{et~al}}}{}


%\if@twocolumn\usepackage{dblfloatfix}\fi
\usepackage{ifxetex}
\ifxetex\else\if@twocolumn\@ifpackageloaded{stfloats}{}{\usepackage{dblfloatfix}}\fi\fi

\AtBeginDocument{
\expandafter\ifx\csname eqalign\endcsname\relax
\def\eqalign#1{\null\vcenter{\def\\{\cr}\openup\jot\m@th
  \ialign{\strut$\displaystyle{##}$\hfil&$\displaystyle{{}##}$\hfil
      \crcr#1\crcr}}\,}
\fi
}

%For fixing hardfail when unicode letters appear inside table with endfloat
\AtBeginDocument{%
  \@ifpackageloaded{endfloat}%
   {\renewcommand\efloat@iwrite[1]{\immediate\expandafter\protected@write\csname efloat@post#1\endcsname{}}}{\newif\ifefloat@tables}%
}%

\def\BreakURLText#1{\@tfor\brk@tempa:=#1\do{\brk@tempa\hskip0pt}}
\let\lt=<
\let\gt=>
\def\processVert{\ifmmode|\else\textbar\fi}
\let\processvert\processVert

\@ifundefined{subparagraph}{
\def\subparagraph{\@startsection{paragraph}{5}{2\parindent}{0ex plus 0.1ex minus 0.1ex}%
{0ex}{\normalfont\small\itshape}}%
}{}

% These are now gobbled, so won't appear in the PDF.
\newcommand\role[1]{\unskip}
\newcommand\aucollab[1]{\unskip}
  
\@ifundefined{tsGraphicsScaleX}{\gdef\tsGraphicsScaleX{1}}{}
\@ifundefined{tsGraphicsScaleY}{\gdef\tsGraphicsScaleY{.9}}{}
% To automatically resize figures to fit inside the text area
\def\checkGraphicsWidth{\ifdim\Gin@nat@width>\linewidth
	\tsGraphicsScaleX\linewidth\else\Gin@nat@width\fi}

\def\checkGraphicsHeight{\ifdim\Gin@nat@height>.9\textheight
	\tsGraphicsScaleY\textheight\else\Gin@nat@height\fi}

\def\fixFloatSize#1{}%\@ifundefined{processdelayedfloats}{\setbox0=\hbox{\includegraphics{#1}}\ifnum\wd0<\columnwidth\relax\renewenvironment{figure*}{\begin{figure}}{\end{figure}}\fi}{}}
\let\ts@includegraphics\includegraphics

\def\inlinegraphic[#1]#2{{\edef\@tempa{#1}\edef\baseline@shift{\ifx\@tempa\@empty0\else#1\fi}\edef\tempZ{\the\numexpr(\numexpr(\baseline@shift*\f@size/100))}\protect\raisebox{\tempZ pt}{\ts@includegraphics{#2}}}}

%\renewcommand{\includegraphics}[1]{\ts@includegraphics[width=\checkGraphicsWidth]{#1}}
\AtBeginDocument{\def\includegraphics{\@ifnextchar[{\ts@includegraphics}{\ts@includegraphics[width=\checkGraphicsWidth,height=\checkGraphicsHeight,keepaspectratio]}}}

\DeclareMathAlphabet{\mathpzc}{OT1}{pzc}{m}{it}

\def\URL#1#2{\@ifundefined{href}{#2}{\href{#1}{#2}}}

%%For url break
\def\UrlOrds{\do\*\do\-\do\~\do\'\do\"\do\-}%
\g@addto@macro{\UrlBreaks}{\UrlOrds}



\edef\fntEncoding{\f@encoding}
\def\EUoneEnc{EU1}
\makeatother
\def\floatpagefraction{0.8} 
\def\dblfloatpagefraction{0.8}
\def\style#1#2{#2}
\def\xxxguillemotleft{\fontencoding{T1}\selectfont\guillemotleft}
\def\xxxguillemotright{\fontencoding{T1}\selectfont\guillemotright}

\newif\ifmultipleabstract\multipleabstractfalse%
\newenvironment{typesetAbstractGroup}{}{}%

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\AtBeginDocument{\let\citet\cite\let\citep\cite}
\usepackage[numbers,sort&compress,numbers,sort&compress]{natbib}


\AtBeginDocument{\let\citet\cite\let\citep\cite}
\newif\ifnokeywords\nokeywordsfalse
\def\abbrvJournalTitle{Future J. Pharm. Health. Sci.}
\def\jrnlurlname{fjphs}
\usepackage{balance}

\makeatletter\input{size10-pointfive.clo}\makeatother%
\definecolor{kwdboxcolor}{RGB}{242,242,242}
\usepackage[hidelinks,colorlinks=true,allcolors=blue]{hyperref}
\linespread{1}                 
\def\floatpagefraction{0.8}

\usepackage[paperheight=11.69in,paperwidth=8.26in,top=1in,bottom=1in,left=1in,right=.75in,headsep=24pt]{geometry}

\usepackage{multirow-custom}

\makeatletter

\def\hlinewd#1{%
  \noalign{\ifnum0=`}\fi\hrule \@height #1%
  \futurelet\reserved@a\@xhline}
\def\tbltoprule{\hlinewd{1pt}\\[-14pt]}
\def\tblbottomrule{\noalign{\vspace*{6pt}}\hline\noalign{\vspace*{2pt}}}
\def\tblmidrule{\hline\noalign{\vspace*{2pt}}}



\let\@articleType\@empty
\let\@journalDoi\@empty
\let\@journalVolume\@empty
\let\@journalIssue\@empty
\let\@crossMarkLink\@empty
\let\@receivedDate\@empty
\let\@acceptedDate\@empty
\let\@revisedDate\@empty
\let\@publishedDate\@empty
\let\@copyrightYear\@empty
\let\@firstPage\@empty
\let\@eISSN\@empty
\let\@pISSN\@empty
\def\eISSN#1{\gdef\@eISSN{#1}}
\def\pISSN#1{\gdef\@pISSN{#1}}
\def\articleType#1{\gdef\@articleType{#1}}
\def\journalDoi#1{\gdef\@journalDoi{#1}}
\def\crossMarkLink#1{\gdef\@crossMarkLink{#1}}
\def\receivedDate#1{\gdef\@receivedDate{#1}}
\def\acceptedDate#1{\gdef\@acceptedDate{#1}}
\def\revisedDate#1{\gdef\@revisedDate{#1}}
\def\publishedDate#1{\gdef\@publishedDate{#1}}
\def\copyrightYear#1{\gdef\@copyrightYear{#1}}
\def\journalVolume#1{\gdef\@journalVolume{#1}}
\def\journalIssue#1{\gdef\@journalIssue{#1}}
\def\firstPage#1{\gdef\@firstPage{#1}}


\def\author#1{%
  \gdef\@author{%
    \hskip-\dimexpr(\tabcolsep)\hskip5pt%
    \parbox{\dimexpr\textwidth-1pt}%
    {\fontsize{11}{13}\selectfont\raggedright #1}%
  }%
}


\usepackage{pharmascope-abs}
\usepackage{caption}
\usepackage{lastpage}
\usepackage{fancyhdr}
\usepackage[noindentafter,explicit]{titlesec}
\usepackage{fontspec}

\setmainfont[%
BoldFont=cambriab.ttf,%
ItalicFont=CAMBRIAI.TTF,%
BoldItalicFont=CAMBRIAZ.TTF]{Cambria.ttf}

\usepackage{qrcode}

%\def\abbrvJournalTitle{Future J. Pharm. Health. Sci.}
\def\jshort{fjphs}

\def\title#1{%
  \gdef\@title{%
%      \vspace*{-20pt}%
       \vspace*{-48pt}
       \ifx\@articleType\@empty\else{\fontsize{10}{12}\scshape\selectfont\hspace{8pt}\@articleType\hfill\mbox{}\par\vspace{2pt}}\fi%
       \minipage{\linewidth}
         \hrulefill\\[-0.7pt]%
         \parbox{.1\linewidth}{\includegraphics[width=4.2cm]{pharmasprings_logo.png}}\hfill
%         \fcolorbox{kwdboxcolor}{kwdboxcolor}{\parbox{.792\linewidth}{%
         \fcolorbox{kwdboxcolor}{kwdboxcolor}{\parbox{.729\linewidth}{%
          \begin{center}
          \vskip-4pt 
          \scshape\fontsize{18}{20}\selectfont\journalTitle\hfill\end{center}%
          \vspace*{-16pt}{\vspace*{-3.1pt}\fontsize{8}{9}\selectfont Published by Pharma Springs Publication\hfill  Journal Home Page: \href{https://pharmasprings.com/index.php/\jrnlurlname}{\color{blue}\underline{\smash{https://pharmasprings.com/\jrnlurlname}}}}\hspace*{4pt}\mbox{}}}%
       \par\rule{\linewidth}{1.3pt}%
       \endminipage%
    \par\vspace*{9.2pt}\parbox{.98\linewidth}{\linespread{.9}\raggedright\fontsize{14}{17}\selectfont #1}%
    \vspace*{-8pt}%
  }
}


\setlength{\parindent}{0pt}
\setlength{\parskip}{0.4pc plus 1pt minus 1pt}


\fancypagestyle{headings}{%
  \renewcommand{\headrulewidth}{0pt}%
  \renewcommand{\footrulewidth}{0.3pt}
  \fancyhf{}%
  \fancyhead[R]{%
    \fontsize{9.12}{11}\selectfont\RunningAuthor,\ \abbrvJournalTitle\ \@copyrightYear;\space\ifx\@journalVolume\@empty X\else\@journalVolume\fi%
    \ifx\@journalIssue\@empty\else(\@journalIssue)\fi%
    :\ \ifx\@firstPage\@empty 1\else\@firstPage\fi-\pageref*{LastPage}%
  }%
  \fancyfoot[RE]{\fontsize{9.12}{11}\selectfont\textcopyright\ Pharma Springs Publication\ $|$\space \journalTitle}%
  \fancyfoot[LO]{\fontsize{9.12}{11}\selectfont\textcopyright\ Pharma Springs Publication\ $|$\space \journalTitle}%
  \fancyfoot[RO,LE]{\fontsize{9.12}{11}\selectfont\thepage}
}\pagestyle{headings}


                                                         
\fancypagestyle{plain}{%
  \renewcommand{\headrulewidth}{0pt}%
  \renewcommand{\footrulewidth}{0.3pt}%
  \fancyhf{}%
  \fancyhead[R]{%
    \fontsize{9.12}{11}\selectfont\RunningAuthor,\ \abbrvJournalTitle\ \@copyrightYear;\space\ifx\@journalVolume\@empty X\else\@journalVolume\fi%
    \ifx\@journalIssue\@empty\else(\@journalIssue)\fi%
    :\ \ifx\@firstPage\@empty 1\else\@firstPage\fi-\pageref*{LastPage}%
  }%
  \fancyfoot[RE]{\fontsize{9.12}{11}\selectfont\textcopyright\ Pharma Springs Publication\ $|$\space \journalTitle}%
  \fancyfoot[LO]{\fontsize{9.12}{11}\selectfont\textcopyright\ Pharma Springs Publication\ $|$\space \journalTitle}%
  \fancyfoot[RO,LE]{\fontsize{9.12}{11}\selectfont\thepage}
  \ifx\@firstPage\@empty\else\setcounter{page}{\@firstPage}\fi
}


\def\NormalBaseline{\def\baselinestretch{1.1}}
\usepackage{textcase}
\setcounter{secnumdepth}{0}

\titleformat{\section}[block]{\bfseries\boldmath\NormalBaseline\filright\fontsize{10.5}{13}\selectfont}
{\thesection}
{6pt}
{\MakeTextUppercase{#1}}
[]
\titleformat{\subsection}[block]{\bfseries\boldmath\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubsection}
{6pt}
{#1}
[]
\titleformat{\subsubsection}[block]{\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubsubsection}
{6pt}
{#1}
[]
\titleformat{\paragraph}[block]{\NormalBaseline\filright\fontsize{10.5}{10}\selectfont}
{\theparagraph}
{6pt}
{#1}
[]
\titleformat{\subparagraph}[block]{\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubparagraph}
{6pt}
{#1}
[]

\titlespacing{\section}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subsection}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subsubsection}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\paragraph}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subparagraph}{0pt}{.5\baselineskip}{.5\baselineskip}

\captionsetup[figure]{skip=1.4pt,font=bf,labelsep=colon,justification=raggedright,singlelinecheck=false}
\captionsetup[table]{skip=1.4pt,font=bf,labelsep=colon,justification=raggedright,singlelinecheck=false}

\def\bibyear#1{#1}
\def\bibjtitle#1{#1}
\def\bibauand{}
\setlength\bibsep{3pt}
\setlength\bibhang{8pt}
\lefthyphenmin = 3
\makeatother
\date{}
\makeatletter
\usepackage{mdframed}
%\usepackage{balance}
\definecolor{unitednationsblue}{RGB}{222,234,246}
\definecolor{cpboxcolor}{RGB}{211,211,211}
\definecolor{citeboxcolor}{RGB}{242,242,242}
\def\printBio{%
  %\noindent\begin{mdframed}[innerbottommargin=7pt,backgroundcolor=unitednationsblue,hidealllines=true,frametitle={ABOUT AUTHORS},innerleftmargin=7pt,leftmargin=2pt,skipabove=1pt,innertopmargin=2pt,innerbottommargin=1pt,skipbelow=1pt]%
  \noindent\begin{mdframed}[innerbottommargin=7pt,backgroundcolor=unitednationsblue,hidealllines=true,frametitle={ABOUT AUTHORS},innerrightmargin=20pt,rightmargin=4,innerleftmargin=7pt,leftmargin=2pt,skipabove=1pt,innertopmargin=2pt,innerbottommargin=1pt,skipbelow=1pt]%
   \@tempcnta=0
    \loop
      \advance \@tempcnta by 1
      \def\aubioCnt{\the\@tempcnta}
      \vskip1pt
%      \noindent\hspace{-2pt}%\fbox{
%     \vspace*{1pt}
      \raisebox{62pt}%{\begin{minipage}[t]{.35\linewidth}%
      \expandafter\ifx\csname authorImage\aubioCnt\endcsname\relax%
       \else%
         \includegraphics[height=60pt,width=60pt]{\csname authorImage\aubioCnt\endcsname}%height=145pt
       \fi%
      %\end{minipage}
      %}%}
      \hskip 4pt%\fbox{
      \raisebox{52pt}{\begin{minipage}[t]{.74\linewidth}%
        {\fontsize{8}{10}\selectfont{\csname authorName\aubioCnt\endcsname\\[5pt]}}
        \fontsize{8}{10}\selectfont\csname authorDetails\aubioCnt\endcsname\\
      \end{minipage}}
%      }
%     \vskip10pt%
    \ifnum\@tempcnta < \theaubio
    \repeat
%     \vspace*{-16.5pt}%
  \end{mdframed}
}


\makeatother


\def\citeauthor{~Banothu~Srikanth,
              ~Greg~Maryann~Nzubechuwku,
              ~Bello~Munirat~Omowumi,
              ~Jacintah~David~Kolo,
              ~Zoya~Fatima}
\def\citetitle{\textbf{RP-HPLC Method Development and Validation for the Simultaneous Estimation of Ivermectin and Albendazole in its Pure and Combine Dosage Form}}
\def\copyrightstmt{This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial- ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.}
\publishedDate{}
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Feature enabled:
%citation-style: unsrt
%citation-type: numbered
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\usepackage{float}

\begin{document}


\def\RunningAuthor{Banothu Srikanth et al.}
\firstPage{170}
\articleType{Original Article}
\receivedDate{10 May 2022}
\acceptedDate{27 May 2022}
\revisedDate{25 May 2022}
\journalVolume{2}
\journalIssue{3}
\journalDoi{fjphs.v2i3.280}
\copyrightYear{2022}
\eISSN{2583-116X}
\journalDoi{fjphs.v2i3.280}
\def\authorCount{5}
\def\affCount{2}

\def\journalTitle{Future Journal of Pharmaceuticals and Health Sciences}

\title{\textbf{RP-HPLC Method Development and Validation for the Simultaneous Estimation of Ivermectin and Albendazole in its Pure and Combine Dosage Form}}
\author{Banothu~Srikanth\textsuperscript{*}\textsuperscript{1}\textsuperscript{\href{https://orcid.org/0000-0002-9186-2815}{\XeTeXLinkBox{\includegraphics[height=7pt]{orcid-logo-pharmascope.pdf}}}},  
            Greg~Maryann~Nzubechuwku\textsuperscript{2},  
            Bello~Munirat~Omowumi\textsuperscript{2},  
            Jacintah~David~Kolo\textsuperscript{2}, 
            Zoya~Fatima\textsuperscript{2}~\\[5pt]{\textsuperscript{1}Department of Pharmaceutical Analysis and Quality Assurance, St. Mary's Pharmacy College, Deshmukhi (Village), Pochampally (Mandal), Yadadri Bhuvanagiri (Dist)-508284, Telangana, India}~\\{\textsuperscript{2}St. Mary's Pharmacy College, Deshmukhi (Village), Pochampally (Mandal), Yadadri Bhuvanagiri (Dist) - 508284, Telangana, India}}

\begin{abstract}
That whole percentage purification of ivermectin and albendazole seemed to be noticed of being 101.04\% and 99.24\% in both. That whole stability studies specifications just that Ivermectin and Albendazole also including theory trays or trying to chase aspect have been discovered of about be4668, 1.3 and 6089 and 1.2, the resolving seemed to be discovered to also be 6.0. This same methodological approach must of been conclusively proven well according to aspect of this approach (ICH, Q2 (R1)). This same simple linear regression survey adjuvant but rather antifungal medication must have been present in concentration after all 50\ensuremath{\mu}g-250\ensuremath{\mu}g and 5\ensuremath{\mu}g-50\ensuremath{\mu}g as well as linkage coefficient (r\ensuremath{^{2}}) has been encountered to really be 0.999 and 0.999, \% regeneration had been noticed of about be 99.56\% and 99.47\%, \%RSD regarding predictive validity had been 0.2 and 0.2, \% RSD regarding medium accuracy must have been 0.2 and 0.1 respectively. It and accuracy analyze seemed to be exact, comprehensive, as well as consistent LOD value was 3.17 and 5.80, and LOQ value was 0.0172 and 0.212 respectively. Thus the posited RP-HPLC technique will be used for regimen assessment sure Ivermectin and Albendazole in API and Pharmaceutical dosage form. 
\end{abstract}\def\keywordstitle{Keywords}

\begin{keywords}ACE C18 Column,\newline Ivermectin and Albendazole,\newline RP-HPLC
\end{keywords}
\twocolumn[ \maketitle {\printKwdAbsBox}]
\makeatletter{\raggedright{\Large$^\ast$}Corresponding Author\par Name:\ Banothu~Srikanth~\\ Phone:\ +91 7893557404~\\  Email:\ srikanth007banoth@gmail.com
        \par}\vspace*{-13pt}\hrulefill\par\ifx\@eISSN\@empty\else{\fontsize{12}{14}\selectfont eISSN: \@eISSN\hfill pISSN: \@pISSN}\par\fi% 
        \textsc{DOI:}\ \href{https://doi.org/10.26452/\@journalDoi}{\textcolor{blue}{\underline{\smash{https://doi.org/10.26452/\@journalDoi}}}}\par%
        \vspace*{-12pt}\hrulefill\\[5pt]\hypersetup{allcolors=black}\qrcode[version=4,height=1.5cm]{https://doi.org/10.26452/\@journalDoi}\hypersetup{allcolors=blue} \hspace*{10.5pt}\parbox[t]{5cm}{\raisebox{19pt}{\fontsize{9.12}{10.12}\selectfont Production and Hosted by}\\[-13pt]{{\fontsize{12}{14}\selectfont  Pharmasprings.com \\[-1pt]{\fontsize{9.12}{10.12}\selectfont\textcopyright\ \@copyrightYear\ $|$ All rights reserved.}\\[-8pt]\hspace*{-1pt}\rule{.762\columnwidth}{1.2pt}}}}\hypersetup{allcolors=blue}%{\fontsize{12}{14}\selectfont Pharmasprings.com}\par%
        \makeatother
        
    
\section{Introduction}
Novel process had been founded just that quantification after all antifungal medication but rather butyric besides RP-HPLC procedure. 

Its gas chromatograph circumstances had been novel functional is for isolation sure interferon-free rather than sulphonamides while using ace capillary column (4.6\ensuremath{\times}150mm) 5\ensuremath{\mu}, fluid velocity seemed to be 1.2 ml/min, reversed - phase measurement was(70:30 v/v) methyl ester: phosphate - buffered pH 3 (Ionic strength seemed to be adapted to orthophosphoric acid), recognition and classification frequency range had been 240nm. 

That whole indicator have been using was Shimadzu, framework very little. SPD-20MA LC+20ad, software- LC-20 quick fix. 

It's own obtain was mostly recognized to be really 2.733 minutes of time and 3.415 minutes to reach \unskip~\cite{1466726:25385019}.
    
\section{METHODOLOGY}
Liquid chromatography trial was conducted regarding quantitative determination like ivermectin and albendazole by RP- HPLC \unskip~\cite{1466726:25385015}.


\bgroup
\fixFloatSize{images/cc137543-e89c-4278-a881-313e974c3dfd-upicture1.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/cc137543-e89c-4278-a881-313e974c3dfd-upicture1.png}{\includegraphics{images/cc137543-e89c-4278-a881-313e974c3dfd-upicture1.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Showing Trial-1 Injection}}
\label{f-ad8c0276e842}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/62ac96e3-133d-460a-a714-1df8407e631f-upicture2.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/62ac96e3-133d-460a-a714-1df8407e631f-upicture2.png}{\includegraphics{images/62ac96e3-133d-460a-a714-1df8407e631f-upicture2.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Showing Trial-2 Injection}}
\label{f-dad7afaef242}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/0f6e9dbc-16f1-46ed-a933-682cfa7ff757-upicture3.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/0f6e9dbc-16f1-46ed-a933-682cfa7ff757-upicture3.png}{\includegraphics{images/0f6e9dbc-16f1-46ed-a933-682cfa7ff757-upicture3.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Showing Trial-3 Injection}}
\label{f-452b70713254}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/6c149d4e-a48c-4a1f-81c4-4a701ca07bf4-upicture4.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/6c149d4e-a48c-4a1f-81c4-4a701ca07bf4-upicture4.png}{\includegraphics{images/6c149d4e-a48c-4a1f-81c4-4a701ca07bf4-upicture4.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Showing Trial-4 Injections}}
\label{f-997851863230}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/070feba3-8bd1-433a-94ac-0370a4ccee46-upicture5.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/070feba3-8bd1-433a-94ac-0370a4ccee46-upicture5.png}{\includegraphics{images/070feba3-8bd1-433a-94ac-0370a4ccee46-upicture5.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Showing Trial-5 Injections}}
\label{f-ed07910c3f6c}
\end{figure}
\egroup
\textbf{Observation}

It and court case goes to show very little functional disconnection highs inside this are several, because more tribunals have been necessary such as gaining reaches a maximum [Figure~\ref{f-ad8c0276e842}]. In such a court case pair seem to have been divided so although don't have decent pixel density. Really more testing had been important for effective sharp peak [Figure~\ref{f-dad7afaef242}]. In this trial both Ivermectin and Albendazole seemed to be solubilized and there's no decent pixel density. Really more experiments seem to have been required for the proper precision such as sharp peak [Figure~\ref{f-452b70713254}]. Its detachment had been nice; peak form seemed to be nice, really more testing seem to be forced to prevent a single phase full sure reaches a maximum [Figure~\ref{f-997851863230}]. The detachment must've been nice, peak contour had been decent, even though designers deduce that there really is no compelled as a start reducing it and single - phase full after all spikes, thus it is considered because finished method [Figure~\ref{f-ed07910c3f6c}].

\textbf{Proc}\textbf{edure} \textbf{\space }

\textbf{Time to Prepare of Phosphate - Buffered}

2.58 grams of KH\ensuremath{_{2}}PO\ensuremath{_{4}} seems to have been concluded to measure as well as carried even more into the 1000ml flask, diluted or solubilised complete 1000ml of HPLC water as well as ionic strength has been modified to 3 as for orthophosphoric acid. Its standard solution has been samples treated as well as purified \unskip~\cite{1466726:25385030}.

\textbf{Time to Prepare of Reversed-Phase}

Combination a mix of all the above barrier 30 ml (30\%) and 70 ml of methanol (HPLC grade-70\%) but rather argon atmosphere out infrasonic steam bath for five minutes. Separator through 0.22 \ensuremath{\mu} filtration below liquid - liquid extraction \unskip~\cite{1466726:25385013}.

\textbf{Solvents Time to Prepare}

Mobile phase was being used as this same polar solvent.

\textbf{Time to Prepare of Both the Individual Ivermectin Conventional Preparation}

10 mg of ivermectin expected to perform conventional has been sample was weighed and transmitted it into 10 ml freshly washed measuring cylinder and add approximately 2 ml of polar solvent and species threatened with extinction to disperse it effectively making volume turned up towards standard with the more or less about the same diluents (Standard solutions). Even farther dropper beyond 1.5 ml through all of the above standard solution it into a measuring cylinder and also the volume and have been prepared by diluting as much as it with standard and dissolution medium \unskip~\cite{1466726:25385030}. 

\textbf{Time to Prepare of Both the Individual Albendazole Conventional Preparation}

10 mg of albendazole operating conventional has been sample was did weigh transmitted into a 10 ml freshly washed measuring cylinder as well as mix approximately 2ml like polar solvent but also species threatened with extinction to dissolve it effectively making volume up to standard through about the same diluents (stock solution) \unskip~\cite{1466726:25385037}. Additional pipette through 3 ml from all of the above standard solutions it into a 10 ml measuring cylinder as well as had been dissolved up to the standard as well as the dissolution medium.

\textbf{Quantisation Time to Prepare of Such Ivermectin and Albendazole Conventional or Sample Solution}

\textbf{Sample Solution Time to Prepare}

10 mg of ivermectin but also 1 mg albendazole tablet flour were often prepared by weighing as well as transmitted it into a 10 ml freshly washed measuring cylinder, insert most of 2ml like dissolution medium but also species threatened with extinction to disperse it entirely and seeking to make volume turned up to standard with almost about the same solutes (stock solution). Much farther pipette 10ml of all above though standard solution together it into 100ml measuring cylinder as well as then has been solubilised it up to a standard with dissolution medium \unskip~\cite{1466726:25385027}.

\textbf{Stock Solution Time to Prepare}

10 mg ivermectin and 1 mg albendazole operating conventional have been prepared by weighing and transmitted it into a 10ml freshly washed volumetric flask and add approximately 2ml of dissolution medium and species threatened with extinction to disperse it effectively making volume turned up to the standard through almost the same diluents (stock solution). Much farther pipette through 1ml of all the above standard solutes it into a 10ml volumetric flask and had been solubilised up to the standard as well as the dissolution medium \unskip~\cite{1466726:25385023}.

\textbf{Preparation}

10mL of an empty, normal as well as sample have been implanted into the liquid chromatography process and regions for such ivermectin and albendazole the peak value would be used for determining the \% quantisation and using the equation.

\textbf{Standard Calibration}

Tailing component for such reaches a maximum as a result of ivermectin and albendazole in solution of known concentration should be no more than 1.5. Theoretical plates for such ivermectin and albendazole reaches a maximum in the solution of known concentration should never be below than 2000 \unskip~\cite{1466726:25385016}.

\textbf{Analytical Procedure Verification}

\textbf{Specificity }

It and standard calibration such as specific must have been conducted to determine whether there will be each and every intrusion of every harmful by products through initial concentration like insightful maximum. That whole exactness must've been conducted along safe injection blot \unskip~\cite{1466726:25385014}.

\textbf{Linearity}

\textbf{Time to Prepare of Inventory Levels Solution}

10 mg like ivermectin but also 1 mg like albendazole operating conventional seemed to be prepared by weighing and then were transmitted it into a 10ml freshly washed volumetric flask, add approximately 2ml of dissolution medium but rather species threatened with extinction to disperse it effectively making volume turned up to that same record with almost the same diluents \unskip~\cite{1466726:25385022}.

\textbf{Time to Prepare} \textbf{of Level {\textendash} I~(50ppm of Ivermectin and 5 ppm of Albendazole) }

0.5 ml of standard solutions seemed to be considered into the 10ml of volumetric flask but rather prepared by diluting up to standard as well as the dissolution medium.\textbf{\space }

\textbf{Time to Prepare } \textbf{of Level {\textendash} II (100ppm of Ivermectin and 10ppm of Albendazole) }

1 ml of known concentration seemed to be considered into the 10ml of volumetric flask as well as solubilised up to the standard as well as the dissolution medium \unskip~\cite{1466726:25385024}.

\textbf{Preparation of Level {\textendash} III (150 ppm of Ivermectin and 15ppm of Albendazole) }

1.5 ml of standard solution seemed to be considered into the 10ml of volumetric flask but rather prepared by diluting up to the standard as well as the polar solvent \unskip~\cite{1466726:25385031}\textbf{.}

\textbf{Time to Prepare } \textbf{of Level {\textendash} IV (200 ppm of Ivermectin and 20ppm of Albendazole)}

2 ml of standard solution seemed to be considered into the 10ml of volumetric flask but rather dissolved up to the standard as well as the solvent \unskip~\cite{1466726:25385039}.

\textbf{Time to Prepare} \textbf{of Level {\textendash} V (250 ppm of Ivermectin and 25ppm of Albendazole)}

2.5 ml of standard solution seemed to be considered into the 10ml of volumetric flask as well as prepared by diluting up to the standard as well as the dissolution medium.


\bgroup
\fixFloatSize{images/1d83a033-2957-4a40-951b-5d14ff206c2f-upicture6.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/1d83a033-2957-4a40-951b-5d14ff206c2f-upicture6.png}{\includegraphics{images/1d83a033-2957-4a40-951b-5d14ff206c2f-upicture6.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Trying to Show Empty Preparatory Work (Mobile Phase)}}
\label{f-6373518785b9}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/f5719f79-c451-4c6e-b307-9804ffe9d5d4-upicture7.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/f5719f79-c451-4c6e-b307-9804ffe9d5d4-upicture7.png}{\includegraphics{images/f5719f79-c451-4c6e-b307-9804ffe9d5d4-upicture7.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Shown Quantisation of Test Injection 1, 2}}
\label{f-3db5203b07b4}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/5446196e-508c-47a8-b9cb-72ca8f029256-upicture8.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/5446196e-508c-47a8-b9cb-72ca8f029256-upicture8.png}{\includegraphics{images/5446196e-508c-47a8-b9cb-72ca8f029256-upicture8.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Shown Quantisation of Test Injection 1, 2}}
\label{f-e8898b04c68b}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/f5cc320c-49d2-4748-9164-6ed83054e059-upicture9.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/f5cc320c-49d2-4748-9164-6ed83054e059-upicture9.png}{\includegraphics{images/f5cc320c-49d2-4748-9164-6ed83054e059-upicture9.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Displaying Empty (Mobile Phase Preparation)}}
\label{f-9580da379d3c}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/b4ca0fe0-d41c-4590-9618-9fa7845572b6-upicture10.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/b4ca0fe0-d41c-4590-9618-9fa7845572b6-upicture10.png}{\includegraphics{images/b4ca0fe0-d41c-4590-9618-9fa7845572b6-upicture10.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Displaying Optimum Injection}}
\label{f-ae70ee2f301b}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/b5f5b1d3-7705-48c2-a926-a7c2e856064b-upicture11.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/b5f5b1d3-7705-48c2-a926-a7c2e856064b-upicture11.png}{\includegraphics{images/b5f5b1d3-7705-48c2-a926-a7c2e856064b-upicture11.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Displaying Sample Injection}}
\label{f-85ffeb974e4b}
\end{figure}
\egroup
\textbf{Procedure}

Also every level has been infused through into liquid chromatography process but rather absorption spectrum has been evaluated. Narrative a graph like peak area vs accumulation (on x-axis concentration as well as on y-axis peak area) and also the coefficient of correlation seemed to be estimated \unskip~\cite{1466726:25385035}. 

\textbf{Range}

Based on accuracy, predictability and precision information, it could be indicated that perhaps the quantisation procedure seems to be precise, linear as well as high accuracy within wide variety of 50\ensuremath{\mu}g/ml-250\ensuremath{\mu}g/ml but rather 5 \ensuremath{\mu}g/ml-25\ensuremath{\mu}g/ml of ivermectin and albendazole respectively \unskip~\cite{1466726:25385016}.

\textbf{Accuracy}

\textbf{Standard Calibration of Known Concentration}

10mg of ivermectin and 1mg of albendazole operating conventional seemed to be prepared by weighing and transmitted it into a 10ml freshly washed volumetric flask add approximately 2ml of dissolution medium and species threatened with extinction to  


\bgroup
\fixFloatSize{images/e4bc73c3-e710-46ba-a820-7d34a91c2a8e-upicture12.png}
\begin{figure*}[!htbp]
\centering \makeatletter\IfFileExists{images/e4bc73c3-e710-46ba-a820-7d34a91c2a8e-upicture12.png}{\includegraphics{images/e4bc73c3-e710-46ba-a820-7d34a91c2a8e-upicture12.png}}{}
\makeatother 
\caption{\boldmath {Chromatograms Displaying Predictability Level-1 to Level 5 Injections}}
\label{f-6ffb9ceff47b}
\end{figure*}
\egroup
disperse it effectively making volume turned up to a standard among almost the same diluent (stock solution). 

Even farther pipette out 1 ml of all the above standard solute together into a 10 ml measuring cylinder but also was prepared by diluting up to the standard along dissolution medium \unskip~\cite{1466726:25385029}.

\textbf{Time to Prepare of Sample Remedies}

For preparation of 50\% solution (with respect to target assay concentration).

5mg of ivermectin but also 0.5 mg of albendazole operating conventional seemed to be weighed accurately and transmitted it into a 10 ml freshly washed volumetric flask add about 2ml of solvent and species threatened with extinction to disperse it effectively making volume turned up to a standard among almost the same diluent (stock solution). 

Further pipette around 10 ml from the above known concentration it into a 100ml volumetric flask but also then has been prepared by diluting up to the standard as well as the dissolution medium \unskip~\cite{1466726:25385038}.\textbf{\space }


\bgroup
\fixFloatSize{images/87a8a3e3-429d-49f3-a5cb-7e987a34f55f-upicture13.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/87a8a3e3-429d-49f3-a5cb-7e987a34f55f-upicture13.png}{\includegraphics{images/87a8a3e3-429d-49f3-a5cb-7e987a34f55f-upicture13.png}}{}
\makeatother 
\caption{\boldmath {Trying to Show Calculation Plot Ivermectin}}
\label{f-3a048592015f}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/d7adf4f5-47e5-44f3-a06f-267b3ae070a2-upicture14.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/d7adf4f5-47e5-44f3-a06f-267b3ae070a2-upicture14.png}{\includegraphics{images/d7adf4f5-47e5-44f3-a06f-267b3ae070a2-upicture14.png}}{}
\makeatother 
\caption{\boldmath {Trying to Show Calculation Plot Regarding Albendazole}}
\label{f-e5aa19f2be6e}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/63d76f96-5f79-4748-96f0-10de9d06e853-upicture15.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/63d76f96-5f79-4748-96f0-10de9d06e853-upicture15.png}{\includegraphics{images/63d76f96-5f79-4748-96f0-10de9d06e853-upicture15.png}}{}
\makeatother 
\caption{\boldmath {Chromatograms Trying to Show Accuracy-50\% Injection-1, 2, 3}}
\label{f-9d3c3ea1cd33}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/9f59e5ab-600e-4fbe-a13a-6ccac261ba3b-upicture16.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/9f59e5ab-600e-4fbe-a13a-6ccac261ba3b-upicture16.png}{\includegraphics{images/9f59e5ab-600e-4fbe-a13a-6ccac261ba3b-upicture16.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Trying to Show Accurateness -100\% Injection-1, 2, 3}}
\label{f-884be70a8caf}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/12072d7e-1d55-471a-ae61-0f8ed1b7aff8-upicture17.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/12072d7e-1d55-471a-ae61-0f8ed1b7aff8-upicture17.png}{\includegraphics{images/12072d7e-1d55-471a-ae61-0f8ed1b7aff8-upicture17.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Trying to Show Accurateness - 150 \% Injection-1, 2, 3}}
\label{f-ba7b6d2c9058}
\end{figure}
\egroup
\textbf{As a Time to Prepare like 100\% Solution (With Regard to Focus on Quantisation Concentration)}

10 mg of ivermectin and 1 mg of albendazole work conditions were prepared by weighing but also transmitted it into the 10ml freshly washed volumetric flask add approximately 2 ml of dissolution medium and species threatened with extinction to disperse it effectively making volume turned up to the standard along almost the same diluents (stock solution). Further pipette out 1ml of all the above standard solution into 10 ml volumetric flask and then was prepared by diluting it up to a standard as well as the dissolution medium \unskip~\cite{1466726:25385033}.

\textbf{As a Time to Prepare of 150\% Solution (With Regard to Focus on Quantisation Concentration)}

15 mg of ivermectin and 2 mg of albendazole working standards it in to a 10ml freshly washed volumetric flask add approximately 2ml of dissolution medium and species threatened with extinction to disperse it effectively making volume up to the standard with almost the same diluents. Further pipette out 1ml of all the above known concentration together into 10ml volumetric flask and had been dissolved up to the standard as well as the dissolution medium \unskip~\cite{1466726:25385021}.

\textbf{Preparation}

The standard stock solution like accurateness 50\%, 100\% as well as 150\% have been infused into a chromatogram process. Calculate the total amount did find as well as amount added for  Ivermectin as well as Albendazole but also evaluate the individual \% healing as well as average \% restoration virtues \unskip~\cite{1466726:25385025}.

\textbf{Precision}

\textbf{Repeatability}

\textbf{Time to Prepare of Standard Solution}

10 mg of ivermectin and 1 mg of albendazole operating conventional were prepared by weighing and transmitted into a 10ml freshly washed volumetric flask add approximately 2ml of solvent and species threatened with extinction to disperse it effectively making volume up to the standard with almost the same diluents. Further pipette out 1ml of all the 


\bgroup
\fixFloatSize{images/8789deb6-6364-44c2-a4fd-f71551d08e10-upicture18.png}
\begin{figure*}[!htbp]
\centering \makeatletter\IfFileExists{images/8789deb6-6364-44c2-a4fd-f71551d08e10-upicture18.png}{\includegraphics{images/8789deb6-6364-44c2-a4fd-f71551d08e10-upicture18.png}}{}
\makeatother 
\caption{\boldmath {Chromatograms Trying to Show Exactness Infusions - 1 to 5}}
\label{f-ed43c106424a}
\end{figure*}
\egroup

\bgroup
\fixFloatSize{images/96d3ce63-eadb-4f6b-815f-bd47b9b402c7-upicture19.png}
\begin{figure*}[!htbp]
\centering \makeatletter\IfFileExists{images/96d3ce63-eadb-4f6b-815f-bd47b9b402c7-upicture19.png}{\includegraphics{images/96d3ce63-eadb-4f6b-815f-bd47b9b402c7-upicture19.png}}{}
\makeatother 
\caption{\boldmath {Chromatograms Trying toShow Precursor Accuracy Infusions 1 to 5}}
\label{f-09ddf914951a}
\end{figure*}
\egroup
above known concentration it into 10ml volumetric flask and it was solubilised up to the standard as well as the polar solvent \unskip~\cite{1466726:25385020}.

\textbf{Procedure}

The usual mixture is pumped such as 4-fold but instead assessed the world across all six intravenously such as gas chromatography. This same \%RSD just that the world of 5 and/or create new transfusions must've been ended up finding was within the prescribed tolerance \unskip~\cite{1466726:25385028}.

\textbf{Time to Prepare of Known Concentration}

10 mg of ivermectin and 1mg of albendazole operating conventional were sample was weighed and transmitted it into 10ml freshly washed volumetric flask contribute approximately 2ml of dissolution medium as well as sonicate to disperse it effectively making volume up to the standard with almost the same diluents. Further pipette out 1ml of all the above known concentration it into 10ml volumetric flask and it was prepared by diluting up to the standard as well as the dissolution medium \unskip~\cite{1466726:25385017}.

\textbf{Preparation}

The quality sample is injected such as fivefold but rather monitored the realm across all a few treatments through high-performance liquid chromatography. It and \%RSD regarding the world of 5 copy infusions has been ended up finding are within the prescribed tolerance. 


\bgroup
\fixFloatSize{images/4fa8444c-2eea-4305-942e-1491a6038e67-upicture20.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/4fa8444c-2eea-4305-942e-1491a6038e67-upicture20.png}{\includegraphics{images/4fa8444c-2eea-4305-942e-1491a6038e67-upicture20.png}}{}
\makeatother 
\caption{\boldmath {Showing Results for Intermediate Precision of Albendazole}}
\label{f-122a5a1e9a8c}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/0a8e5e4d-1409-4808-887f-217e4d40a044-upicture21.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/0a8e5e4d-1409-4808-887f-217e4d40a044-upicture21.png}{\includegraphics{images/0a8e5e4d-1409-4808-887f-217e4d40a044-upicture21.png}}{}
\makeatother 
\caption{\boldmath {Trying to Show Outcomes Regarding Limit of Quantification}}
\label{f-390739034775}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/9bcbb4b2-aa68-4fc2-8e2e-09192e12da0b-upicture22.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/9bcbb4b2-aa68-4fc2-8e2e-09192e12da0b-upicture22.png}{\includegraphics{images/9bcbb4b2-aa68-4fc2-8e2e-09192e12da0b-upicture22.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Trying to Show Lower Rate of Flow 0.8ml/min}}
\label{f-a2b0c851adbb}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/9de11f5a-1b80-4bc6-b8e4-2fdce24a54cc-upicture23.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/9de11f5a-1b80-4bc6-b8e4-2fdce24a54cc-upicture23.png}{\includegraphics{images/9de11f5a-1b80-4bc6-b8e4-2fdce24a54cc-upicture23.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Trying to Show Lower Rate of Flow 1.2 ml/min}}
\label{f-75d54afd1784}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/8b6cb91c-76e1-4ba4-a134-d8af8f6627a5-upicture24.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/8b6cb91c-76e1-4ba4-a134-d8af8f6627a5-upicture24.png}{\includegraphics{images/8b6cb91c-76e1-4ba4-a134-d8af8f6627a5-upicture24.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Trying to Show Greater Organic Solvents Proportion}}
\label{f-f4e0a06eca17}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/7efb3588-8a9b-41e6-bb93-84b5867b6a8d-upicture25.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/7efb3588-8a9b-41e6-bb93-84b5867b6a8d-upicture25.png}{\includegraphics{images/7efb3588-8a9b-41e6-bb93-84b5867b6a8d-upicture25.png}}{}
\makeatother 
\caption{\boldmath {Chromatogram Trying to Show Lower Organic Solvents Ratio}}
\label{f-a4b3ac87815a}
\end{figure}
\egroup

\begin{table*}[!htbp]
\caption{\boldmath {Trying to Show Biochemical Tests} }
\label{tw-ec4993e25d10}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.3621\linewidth-2\tabcolsep}p{\dimexpr.24169999999999998\linewidth-2\tabcolsep}p{\dimexpr.25619999999999997\linewidth-2\tabcolsep}p{\dimexpr.13999999999999998\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack Name of Compound & \cAlignHack Label Claim & \cAlignHack Amount Taken & \cAlignHack \%purity\\
\tblmidrule 
\cAlignHack Ivermectin &
  \cAlignHack 500 &
  \cAlignHack 754.7 &
  \cAlignHack 99.24\\
\cAlignHack  Albendazole &
  \cAlignHack 2.5 &
  \cAlignHack 735.6 &
  \cAlignHack 101.04\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Predictability Conclusions Regarding Ivermectin} }
\label{tw-09a409c8bdf4}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.16279999999999998\linewidth-2\tabcolsep}p{\dimexpr.304\linewidth-2\tabcolsep}p{\dimexpr.277\linewidth-2\tabcolsep}p{\dimexpr.2562\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack S.No & \cAlignHack Linearity Level & \cAlignHack Concentration & \cAlignHack Area\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack I~&
  \cAlignHack 5ppm &
  \cAlignHack 56472\\
\cAlignHack 2 &
  \cAlignHack II &
  \cAlignHack 10 ppm &
  \cAlignHack 73841\\
\cAlignHack 3 &
  \cAlignHack III &
  \cAlignHack 15ppm &
  \cAlignHack 92655\\
\cAlignHack 4 &
  \cAlignHack IV &
  \cAlignHack 20ppm &
  \cAlignHack 111541\\
\cAlignHack 5 &
  \cAlignHack V &
  \cAlignHack 25ppm &
  \cAlignHack 130567\\
\multicolumn{3}{p{\dimexpr(.7438\linewidth-2\tabcolsep)}}{\cAlignHack Correlation Coefficient} &
  \cAlignHack 0.999\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Predictability Outcomes Regarding Albendazole} }
\label{tw-13cbfdc0eb5a}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.1608\linewidth-2\tabcolsep}p{\dimexpr.2873\linewidth-2\tabcolsep}p{\dimexpr.27910000000000004\linewidth-2\tabcolsep}p{\dimexpr.27279999999999998\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack S.No & \cAlignHack Linearity Level & \cAlignHack Concentration & \cAlignHack Area\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack I~&
  \cAlignHack 50 ppm &
  \cAlignHack 471543\\
\cAlignHack 2 &
  \cAlignHack II &
  \cAlignHack 100 ppm &
  \cAlignHack 656277\\
\cAlignHack 3 &
  \cAlignHack III &
  \cAlignHack 150 ppm &
  \cAlignHack 794999\\
\cAlignHack 4 &
  \cAlignHack IV &
  \cAlignHack 200 ppm &
  \cAlignHack 946124\\
\cAlignHack 5 &
  \cAlignHack V &
  \cAlignHack 250 ppm &
  \cAlignHack 1002139\\
\multicolumn{3}{p{\dimexpr(.7272\linewidth-2\tabcolsep)}}{\cAlignHack Correlation Coefficient} &
  \cAlignHack 0.999\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Trying to Show Statistical Evidence Regarding Ivermectin} }
\label{tw-52b873a3561c}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.2181\linewidth-2\tabcolsep}p{\dimexpr.11990000000000002\linewidth-2\tabcolsep}p{\dimexpr.1752\linewidth-2\tabcolsep}p{\dimexpr.1711\linewidth-2\tabcolsep}p{\dimexpr.13510000000000002\linewidth-2\tabcolsep}p{\dimexpr.1806\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack \%Concentration \mbox{}\protect\newline (at specification level) & \cAlignHack Average \mbox{}\protect\newline area & \cAlignHack Amount added \mbox{}\protect\newline (mg) & \cAlignHack Amount found \mbox{}\protect\newline (mg) & \cAlignHack \% Recovery & \cAlignHack Mean recovery\\
\tblmidrule 
\cAlignHack 50\% &
  \cAlignHack 656659 &
  \cAlignHack 5 &
  \cAlignHack 4.96 &
  \cAlignHack 99.91\% &
  \multicolumn{1}{p{\dimexpr(.1806\linewidth-2\tabcolsep)}}{\multirow{3}{\linewidth}{\cAlignHack 99.56\%}}\\
\cAlignHack 100\% &
  \cAlignHack 1304258 &
  \cAlignHack  10 &
  \cAlignHack  9.98 &
  \cAlignHack 99.18\% &
  \\
\cAlignHack 150\% &
  \cAlignHack 1854608 &
  \cAlignHack 15 &
  \cAlignHack 15.02 &
  \cAlignHack 99.60\% &
  \\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Trying to Show Proper Evidence Regarding Albendazole} }
\label{tw-c690e42a325a}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.2209\linewidth-2\tabcolsep}p{\dimexpr.11299999999999999\linewidth-2\tabcolsep}p{\dimexpr.1848\linewidth-2\tabcolsep}p{\dimexpr.16009999999999998\linewidth-2\tabcolsep}p{\dimexpr.1516\linewidth-2\tabcolsep}p{\dimexpr.1696\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack \%Concentration \mbox{}\protect\newline (at specification level) & \cAlignHack Average \mbox{}\protect\newline area & \cAlignHack Amount added \mbox{}\protect\newline (mg) & \cAlignHack Amount found \mbox{}\protect\newline (mg) & \cAlignHack \% Recovery & \cAlignHack Mean recovery\\
\tblmidrule 
\cAlignHack 50\% &
  \cAlignHack 65312 &
  \cAlignHack 0.5 &
  \cAlignHack 0.99 &
  \cAlignHack 99.53\% &
  \multicolumn{1}{p{\dimexpr(.1696\linewidth-2\tabcolsep)}}{\multirow{3}{\linewidth}{\cAlignHack 99.47\%}}\\
\cAlignHack 100\% &
  \cAlignHack 124509 &
  \cAlignHack 1.0 &
  \cAlignHack 1.05 &
  \cAlignHack 99.38\% &
  \\
\cAlignHack 150\% &
  \cAlignHack 178517 &
  \cAlignHack 1.5 &
  \cAlignHack 1.495 &
  \cAlignHack 99.52\% &
  \\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Showing \% Relative Standard Deviation Outcomes Regarding Ivermectin} }
\label{tw-69ec5938495e}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.1934\linewidth-2\tabcolsep}p{\dimexpr.2066\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack  & \cAlignHack Peak Name & \cAlignHack RT & \cAlignHack Area (\ensuremath{\mu }V*sec) & \cAlignHack Height (\ensuremath{\mu }V)\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.343 &
  \cAlignHack 1302729 &
  \cAlignHack 248455\\
\cAlignHack 2 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.343 &
  \cAlignHack 1309759 &
  \cAlignHack 248699\\
\cAlignHack 3 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.344 &
  \cAlignHack 1302947 &
  \cAlignHack 249526\\
\cAlignHack 4 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.344 &
  \cAlignHack 1303977 &
  \cAlignHack 246695\\
\cAlignHack 5 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.345 &
  \cAlignHack 1303236 &
  \cAlignHack 250012\\
\cAlignHack Mean &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 1304529.8 &
  \cAlignHack \\
\cAlignHack Std. Dev. &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 2961.1 &
  \cAlignHack \\
\cAlignHack \% RSD &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 0.2 &
  \cAlignHack \\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Show \% RSD Out Comes Regarding Albendazole} }
\label{tw-be96c99e143d}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.1801\linewidth-2\tabcolsep}p{\dimexpr.2199\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}p{\dimexpr.205\linewidth-2\tabcolsep}p{\dimexpr.195\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack  & \cAlignHack Peak Name & \cAlignHack RT & \cAlignHack Area (\ensuremath{\mu }V*sec) & \cAlignHack Height (\ensuremath{\mu }V)\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack Albendazole &
  \cAlignHack 3.285 &
  \cAlignHack 124263 &
  \cAlignHack 19458\\
\cAlignHack 2 &
  \cAlignHack Albendazole &
  \cAlignHack 3.287 &
  \cAlignHack 124487 &
  \cAlignHack 19634\\
\cAlignHack 3 &
  \cAlignHack Albendazole &
  \cAlignHack 3.287 &
  \cAlignHack 124175 &
  \cAlignHack 19600\\
\cAlignHack 4 &
  \cAlignHack Albendazole &
  \cAlignHack 3.288 &
  \cAlignHack 124894 &
  \cAlignHack 19327\\
\cAlignHack 5 &
  \cAlignHack Albendazole &
  \cAlignHack 3.288 &
  \cAlignHack 124495 &
  \cAlignHack 19540\\
\cAlignHack Mean &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 124462.7 &
  \cAlignHack \\
\cAlignHack Std. Dev. &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 278.6 &
  \cAlignHack \\
\cAlignHack \% RSD &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 0.2 &
  \cAlignHack \\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Trying to Show Outcomes Regarding Medium Accuracy of Ivermectin} }
\label{tw-7c8d744611df}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.19\linewidth-2\tabcolsep}p{\dimexpr.21\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack  & \cAlignHack Peak Name & \cAlignHack RT & \cAlignHack Area (\ensuremath{\mu }V*sec) & \cAlignHack Height (\ensuremath{\mu }V)\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.342 &
  \cAlignHack 1305937 &
  \cAlignHack 247870\\
\cAlignHack 2 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.343 &
  \cAlignHack 1306476 &
  \cAlignHack 246764\\
\cAlignHack 3 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.344 &
  \cAlignHack 1304520 &
  \cAlignHack 245696\\
\cAlignHack 4 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.344 &
  \cAlignHack 1300148 &
  \cAlignHack 247140\\
\cAlignHack 5 &
  \cAlignHack Ivermectin &
  \cAlignHack 2.345 &
  \cAlignHack 1308271 &
  \cAlignHack 247280\\
\cAlignHack Mean &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 1305070.2 &
  \cAlignHack \\
\cAlignHack Std. Dev. &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 3061.8 &
  \cAlignHack \\
\cAlignHack \% RSD &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 0.2 &
  \cAlignHack \\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Showing Outcomes Regarding Medium Accuracy of Albendazole} }
\label{tw-e283f237a0f7}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.20\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}p{\dimexpr.20\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack  & \cAlignHack Peak Name & \cAlignHack RT & \cAlignHack Area (\ensuremath{\mu }V*sec) & \cAlignHack Height (\ensuremath{\mu }V)\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack Albendazole &
  \cAlignHack 3.278 &
  \cAlignHack 122962 &
  \cAlignHack 19165\\
\cAlignHack 2 &
  \cAlignHack Albendazole &
  \cAlignHack 3.281 &
  \cAlignHack 122487 &
  \cAlignHack 19115\\
\cAlignHack 3 &
  \cAlignHack Albendazole &
  \cAlignHack 3.281 &
  \cAlignHack 122632 &
  \cAlignHack 19073\\
\cAlignHack 4 &
  \cAlignHack Albendazole &
  \cAlignHack 3.281 &
  \cAlignHack 122626 &
  \cAlignHack 19003\\
\cAlignHack 5 &
  \cAlignHack Albendazole &
  \cAlignHack 3.283 &
  \cAlignHack 122702 &
  \cAlignHack 19123\\
\cAlignHack Mean &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 122681.8 &
  \cAlignHack \\
\cAlignHack Std. Dev. &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 174.8 &
  \cAlignHack \\
\cAlignHack \% RSD &
  \cAlignHack  &
  \cAlignHack  &
  \cAlignHack 0.1 &
  \cAlignHack \\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Trying to Show Outcomes Regarding Detection Limit} }
\label{tw-dbb04866e048}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.2334\linewidth-2\tabcolsep}p{\dimexpr.36620000000000005\linewidth-2\tabcolsep}p{\dimexpr.2147\linewidth-2\tabcolsep}p{\dimexpr.1857\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack Drug Name & \cAlignHack Standard Deviation (\ensuremath{\sigma  }) & \cAlignHack Slope (s) & \cAlignHack LOD (\ensuremath{\mu}g)\\
\tblmidrule 
\cAlignHack Ivermectin &
  \cAlignHack 382625.50 &
  \cAlignHack 572175863 &
  \cAlignHack 3.17\\
\cAlignHack Albendazole &
  \cAlignHack 5862.40 &
  \cAlignHack 467579210 &
  \cAlignHack 0.0172\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Showing Results for Limit of Quantitation} }
\label{tw-9ac4924bcf8f}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.2292\linewidth-2\tabcolsep}p{\dimexpr.3683\linewidth-2\tabcolsep}p{\dimexpr.20230000000000004\linewidth-2\tabcolsep}p{\dimexpr.20019999999999996\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack Drug Name & \cAlignHack Standard Deviation(\ensuremath{\sigma  }) & \cAlignHack Slope(s) & \cAlignHack LOQ(\ensuremath{\mu}g)\\
\tblmidrule 
\cAlignHack Ivermectin &
  \cAlignHack 381727.80 &
  \cAlignHack 583265980 &
  \cAlignHack 5.80\\
\cAlignHack  Albendazole &
  \cAlignHack 5681.30 &
  \cAlignHack 469828490 &
  \cAlignHack 0.212\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Trying to Show Standard Calibration Outcomes Regarding Ivermectin} }
\label{tw-c6876739de68}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.1525\linewidth-2\tabcolsep}p{\dimexpr.34129999999999995\linewidth-2\tabcolsep}p{\dimexpr.2562\linewidth-2\tabcolsep}p{\dimexpr.25\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack S. No & \cAlignHack Flow Rate (ml/min)  & \multicolumn{2}{p{\dimexpr(.50620000000000005\linewidth-2\tabcolsep)}}{\cAlignHack System Suitability Results }\\
\rowcolor{kwdboxcolor}\cAlignHack  & \cAlignHack  & \cAlignHack USP Plate Count & \cAlignHack USP Tailing\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack 0.8 &
  \cAlignHack 5339 &
  \cAlignHack 1.4\\
\cAlignHack 2 &
  \cAlignHack  1 &
  \cAlignHack 4668 &
  \cAlignHack 1.3\\
\cAlignHack 3 &
  \cAlignHack 1.2 &
  \cAlignHack 5216  &
  \cAlignHack 1.4\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Showing Standard Calibration Outcomes Regarding Albendazole} }
\label{tw-db22eebe0075}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.14840000000000003\linewidth-2\tabcolsep}p{\dimexpr.3309\linewidth-2\tabcolsep}p{\dimexpr.2707\linewidth-2\tabcolsep}p{\dimexpr.25\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack S. No & \cAlignHack Flow Rate (ml/min) & \multicolumn{2}{p{\dimexpr(.5207\linewidth-2\tabcolsep)}}{\cAlignHack System Suitability Results}\\
\rowcolor{kwdboxcolor}\cAlignHack  & \cAlignHack  & \cAlignHack USP Plate Count & \cAlignHack USP Tailing\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack 0.8 &
  \cAlignHack 7036 &
  \cAlignHack  1.3\\
\cAlignHack 2 &
  \cAlignHack 1 &
  \cAlignHack 6089 &
  \cAlignHack 1.2\\
\cAlignHack 3 &
  \cAlignHack 1.2 &
  \cAlignHack 6998 &
  \cAlignHack 1. 3\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Trying to Show Standard Calibration Outcomes Regarding Ivermectin} }
\label{tw-33c346f3f9a8}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.12970000000000002\linewidth-2\tabcolsep}p{\dimexpr.46160000000000004\linewidth-2\tabcolsep}p{\dimexpr.2044\linewidth-2\tabcolsep}p{\dimexpr.2043\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack S. No & \cAlignHack Modify Through Ingredients Component Inside the Organic Phase & \multicolumn{2}{p{\dimexpr(.40870000000000005\linewidth-2\tabcolsep)}}{\cAlignHack Stability Studies Outcomes }\\
\rowcolor{kwdboxcolor}\cAlignHack  & \cAlignHack  & \cAlignHack USP Plate Count & \cAlignHack USP Tailing\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack 5 \% less &
  \cAlignHack 6232 &
  \cAlignHack 1.4\\
\cAlignHack 2 &
  \cAlignHack *Actual &
  \cAlignHack 4668 &
  \cAlignHack  1.3\\
\cAlignHack 3 &
  \cAlignHack 5 \% more &
  \cAlignHack 6387  &
  \cAlignHack 1.4\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Trying to Show Stability Studies Outcomes Regarding Albendazole} }
\label{tw-75b326ef8e46}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.11719999999999999\linewidth-2\tabcolsep}p{\dimexpr.4969\linewidth-2\tabcolsep}p{\dimexpr.22099999999999998\linewidth-2\tabcolsep}p{\dimexpr.1649\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}\cAlignHack S. No & \cAlignHack Modify through ingredients component inside the organic phase & \multicolumn{2}{p{\dimexpr(.38589999999999996\linewidth-2\tabcolsep)}}{\cAlignHack Stability studies outcomes}\\
\rowcolor{kwdboxcolor}\cAlignHack  & \cAlignHack  & \cAlignHack USP Plate Count & \cAlignHack USP Tailing\\
\tblmidrule 
\cAlignHack 1 &
  \cAlignHack 5 \% less &
  \cAlignHack 5437 &
  \cAlignHack  1.3\\
\cAlignHack 2 &
  \cAlignHack *Actual &
  \cAlignHack 6089 &
  \cAlignHack  1.2\\
\cAlignHack 3 &
  \cAlignHack 5 \% more &
  \cAlignHack  4817 &
  \cAlignHack  1.2\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}
\textbf{Limit of Detection (LOD)}

LOD can also be determined based on the standard error of the mean of such reaction (SD) and this same slope of both the standard calibration (s) at stages estimating that whole limit of detection as per the equation. 

The standard error of the mean of such reaction can indeed be selected depending on the standard error of the mean of y-intercepts of linear interpolation paths \unskip~\cite{1466726:25385036}.

\textbf{Limit of Quantification}

LOQ's can indeed be determined based here on standard error of the mean of a rebuttal (SD) or the hill of a calibration plot (s) per the methodology. Again, the standard error of responding can indeed be defined based here on standard error of the mean like y-intercepts after all correlation markings \unskip~\cite{1466726:25385032}. 

\textbf{Structural Rigidity}

Even though portion of that whole structural rigidity, premeditated transformation there in air flow was manufactured to judge this same affect here on technique.\textbf{\space }The rate of flow has been ranged at 0.4ml/min to 0.6 ml/min. Solution of known concentration 150 ppm of ivermectin and 15 ppm of albendazole was able to prepare and analyzed and interpreted that use the various mass flow and including process rate of flow \unskip~\cite{1466726:25385026}.\textbf{\space }

An ingredients type as well as concentration through mobile phase has been differed through the 65\% to75 \%standard solution 150 \ensuremath{\mu}g/ml of Ivermectin and15 \ensuremath{\mu}g/ml of Albendazole have been able to prepare as well as evaluated just using differed mobile phase composition together with the exact mobile phase composition within technique \unskip~\cite{1466726:25385018}.
    
\section{RESULTS AND DISCUSSIONS}
The present research mentioned with in theory seemed to be effort to create a brand new concept screening and verification for such simultaneous determination of ivermectin and albendazole by RP-HPLC technique. Systematic review confirms that there will be no analytical procedures revealed for such quantitative determination ivermectin and albendazole by RP-HPLC process. Hence, it seemed to be noticed a certain, there will be a need of recent analytical design/development for such quantitative determination of ivermectin and albendazole in pharmaceutical formulations structure [Figure~\ref{f-6373518785b9}].

\textbf{Quantisation Method of Calculating Such as Ivermectin and Albendazole}

The quantitation study was conducted is for ivermectin and albendazole [Table~\ref{tw-ec4993e25d10}]. Also, every three transfusions of sample and conventional seem to have been infused into liquid chromatography process [Figure~\ref{f-3db5203b07b4}  \& Figure~\ref{f-e8898b04c68b}].

The hydraulic retention of ivermectin and albendazole seemed to be encountered to be 2.344 mins and 3.284 mins respectively. The standard calibration specifications for ivermectin and albendazole also including hypothetical panels and trying to overtake element were noticed to be 4668,1.3 and 6089,1.2. Precision was 6.0 the \% purified ivermectin and albendazole in pharmaceutical formulations structure was encountered to be 99.24 and 101.04\% respectively.

\textbf{Validation Report}

\textbf{Specificity}

That whole method validation as a specific seemed to be conducted to find whether there was any whatever intervention of every remove pollutants out residence time sure quantitative climax. An analysis was done through trying to inject empty [Figure~\ref{f-9580da379d3c}, Figure~\ref{f-ae70ee2f301b}, Figure~\ref{f-85ffeb974e4b}].

The selectivity assay was done for ivermectin and albendazole. That was encountered that there would be no involvement of unwanted substances in residence time of quantitative maximum.

\textbf{Linearity }

The predictability analysis was done for the concentration of 50 ppm to 250 ppm and 5ppm to 25 ppm level. One per threshold was inoculated into liquid chromatography process [Table~\ref{tw-09a409c8bdf4}  and Table~\ref{tw-13cbfdc0eb5a}]. 

The world for every stage was being used for method of calculating of coefficient of correlation [Figure~\ref{f-6ffb9ceff47b}]. 

The predictability analysis was done for range of concentrations of 50. \ensuremath{\mu}g-250\ensuremath{\mu}g and 5\ensuremath{\mu}g-50\ensuremath{\mu}g of ivermectin and albendazole and the coefficient of correlation was encountered to be 0.999 and 0.999 [Figure~\ref{f-3a048592015f}, Figure~\ref{f-e5aa19f2be6e}]. 

\textbf{Accuracy }

The accuracy study was performed for 50\%, 100\% and 150 \% for Ivermectin and Albendazole. Each level was injected in triplicate into chromatographic system. The area of each level was used for calculation of \% recovery [Figure~\ref{f-9d3c3ea1cd33}, Figure~\ref{f-884be70a8caf} and Figure~\ref{f-ba7b6d2c9058}].

The precision analysis was carried for \% regeneration of ivermectin and albendazole [Table~\ref{tw-52b873a3561c}  and Table~\ref{tw-c690e42a325a}]. The \% recovery was encountered to be 99.56\% and 99.47\% respectively (nMt 98\% and nmt 102\%).

\textbf{Precision}

\textbf{Repeatability}

The quality sample is injected for 5 percent and evaluated the world for all 5 infusions in HPLC. The \%RSD for the world of five recreate infusions has been encountered are within the prescribed limit.

\textbf{Intermediate Precision/Ruggedness}

The standard sample was injected for five times and evaluated the world for all five infusions in HPLC. The \%rsd for the world of five recreate injections was found are within the defined range.

\textbf{Repeatability }

The accuracy analysis was done for five infusions of ivermectin and albendazole. Also, every optimum injection was inoculated into liquid chromatography process. The area of each Standard injection was used for calculation of \% RSD.

The Method precision study was performed for the \%RSD of Ivermectin and Albendazole was found to be 0.2 and 0.2 (NMT 2) [Figure~\ref{f-ed43c106424a}, Table~\ref{tw-69ec5938495e} and  Table~\ref{tw-be96c99e143d}].

\textbf{Intermediate Precision/Ruggedness}

The alternate accuracy analysis was done for five infusions of ivermectin and albendazole. Each optimum injection was infused into liquid chromatography process. The world of each optimum injection is being used for method of calculating of \% RSD.

The alternate accuracy was accomplished for \% RSD of ivermectin and albendazole seemed to be encountered of being 0.2 and 0.1 respectively (nmt 2) [Figure~\ref{f-09ddf914951a}, Table~\ref{tw-7c8d744611df} and Table~\ref{tw-e283f237a0f7}].

\textbf{Detection Limit}

LOD's can be determined based upon that standard error of the reaction (SD) and the gradient of both the standard calibration (s) at thresholds estimating the limit of detection as per the equation. The standard error of both the reaction can indeed be defined based on the standard error of the mean of y-intercepts of linear interpolation lines.

The LOD was performed for Ivermectin and Albendazole was found to be 3.17and 0.0172 respectively [Table~\ref{tw-dbb04866e048} and sFigure~\ref{f-122a5a1e9a8c}].

\textbf{Data Compression Limit} \textbf{\space }

LOQ's can indeed be determined based on the standard error of the mean of the reaction (SD) and the gradient of the standard calibration (s) according to the method [Table~\ref{tw-9ac4924bcf8f}]. Again, the standard error of the mean of the reaction can really be calculated based on the standard error of the mean of y-intercepts of correlation lines [Figure~\ref{f-390739034775}].

The LOQ was performed for Ivermectin and Albendazole was found to be 5.80 and 0.212 respectively. 

\textbf{Robustness}

The structural rigidity was managed to perform for such rate of flow different variants from 0.4ml/min to 0.6ml/min and organic phase ratio variance from it more organic solvents to some less mobile phase ratio for ivermectin and albendazole [Figure~\ref{f-a2b0c851adbb} and Figure~\ref{f-75d54afd1784}]. The strategy is powerful only within less fluid predicament and the strategy is strong although by transformation in the organic phase \ensuremath{\pm}5\%.

The outcomes are articulated on assessment from the above outcomes, it could be arrived at the conclusion that its modification in rate of flow directly affected the strategy substantially [Table~\ref{tw-c6876739de68}  \& Table~\ref{tw-db22eebe0075}]. Therefore, it signifies that the strategy is powerful although by transformation in the rate of flow \ensuremath{\pm}0.2ml/min. The strategy is powerful only within lower fluid predicament [Figure~\ref{f-f4e0a06eca17} and Figure~\ref{f-a4b3ac87815a}].

On analysis of all the above outcomes, it could be indicated that its modification in\ensuremath{\pm}5\%. Ingredients type and concentration inside the organic phase directly impacted the strategy noticeably [Table~\ref{tw-33c346f3f9a8} \& Table~\ref{tw-75b326ef8e46}]. Therefore, it suggests that the strategy is powerful although by modifying the reversed - phase \ensuremath{\pm}5\%.
    
\section{CONCLUSION}
A newly designed methodology has been developed for simultaneous estimation of ivermectin and albendazole through RP-HPLC process. The liquid chromatography circumstances seemed to be widely used to develop for such isolation of ivermectin and albendazole through using ace c18 column (4.6\ensuremath{\times}150mm) 5\ensuremath{\mu}, flow velocity was 1.2 ml/min, reversed - phase proportion has been (70: 30 v/v) methanol: phosphate - buffered ph 3 (ph was amended as well as the orthophosphoric acid), identification frequency range was 240nm. The instrument used was Shimadzu, model No. SPD-20MA LC+20AD, Software- LC-20 Solution. The single phase full seemed to be noticed of being 2.733 mins and 3.415 mins. The \% purity of ivermectin and albendazole was encountered to be 101.04\% and 99.24\% respectively. The method validation specifications for ivermectin and albendazole such as hypothetical plates and trying to overtake factor were found of being 4668,1.3 and 6089 and 1.2, the precision was encountered to be 6.0. The analytical procedure was independently verified so according to ich guidelines (ich, q2 (r1)). The predictability research n ivermectin and albendazole was present in range of concentrations of 50\ensuremath{\mu}g-250\ensuremath{\mu}g and 5\ensuremath{\mu}g-50\ensuremath{\mu}g and coefficient of correlation (r2) was found to be 0.999 and 0.999, \% rehabilitation was noticed to be 99.56\% and 99.47\%, \%RSD for predictive validity was 0.2 and 0.2, \% RSD for transitional specificity was 0.2 and 0.1respectively. The specificity investigate was accurate, powerful, and consistent. Lod value was 3.17 and 5.80, and limit of quantification value was 0.0172 and 0.212 respectively. And thus the tried to suggest RP-HPLC procedure could be used for procedure evaluation of ivermectin and albendazole in API and pharmaceutical formulations structure.

\textbf{Funding Support}

The authors declare that they have no funding support for this study.

\textbf{Conflict of Interest}

The authors declare that there is no conflict of interest.
    

\bibliographystyle{unsrt}

\bibliography{\jobname}\vspace*{20pt} 
\begin{mdframed}[backgroundcolor=cpboxcolor,hidealllines=true,innerbottommargin=7pt,innerrightmargin=1pt,rightmargin=1pt,innerleftmargin=1pt,leftmargin=2pt,skipabove=1pt,innertopmargin=2pt,innerbottommargin=1pt,skipbelow=1pt]%
{\fontsize{8.5}{10}\selectfont\textbf{Copyright:}~\copyrightstmt}	
\end{mdframed}
        
\begin{mdframed}[backgroundcolor=citeboxcolor,hidealllines=true,innerbottommargin=7pt,innerrightmargin=4pt,rightmargin=4pt,innerleftmargin=2pt,leftmargin=2pt,skipabove=1pt,innertopmargin=2pt,innerbottommargin=4pt,skipbelow=2pt]%
{\fontsize{8.5}{10}\selectfont\textbf{Cite~this~article:}~\citeauthor.~\citetitle.\space\makeatletter\abbrvJournalTitle\ \@copyrightYear;\ \ifx\@journalVolume\@empty X\else\@journalVolume\fi\ifx\@journalIssue\@empty\else(\@journalIssue)\fi:\ \ifx\@firstPage\@empty 1\else\@firstPage\fi-\pageref*{LastPage}.\makeatother}	
\end{mdframed}
\vskip-1.1pc

\vskip.5pc
{\includegraphics[width=5cm]{pharmasprings_logo.png}}
~\\
{\fontsize{9.12}{10.12}\selectfont\textcopyright\ \makeatletter\@copyrightYear\makeatother\ Pharma Springs Publication.}

\end{document}
